Administration of CREON ® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: An in vitro study

Clinical Drug Investigation

Volumn 31, Issue 7, 2011, Pages

  Shlieout, George ^a   Koerner, Andreas ^a   Maffert, Mario ^a   Forssmann, Kristin ^a   Caras, Steven ^b  

^a ABBOTT GMBH AND CO KG   (Germany)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Cystic fibrosis; Enteral feeding; Exocrine pancreatic insufficiency; Pancrelipase.

Indexed keywords

KREON; PANCRELIPASE; TRIACYLGLYCEROL LIPASE; WATER;

ARTICLE; BABY FOOD; BANANA; CHEMICAL COMPOSITION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DELAYED DRUG RELEASE; DRUG ABSORPTION; DRUG CAPSULE; DRUG FORMULATION; DRUG PELLET; DRUG SOLUBILITY; ENTERIC COATED TABLET; ENZYME ACTIVITY; GASTRIC RESISTANCE; HUMAN; IN VITRO STUDY; PH; PRIORITY JOURNAL; STOMACH FUNCTION; STOMACH TUBE; SYRINGE;

DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; ENTERAL NUTRITION; ENZYME REPLACEMENT THERAPY; ENZYME STABILITY; FEASIBILITY STUDIES; FOOD; PANCRELIPASE; SOLUBILITY;

EID: 79957789624     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11592990-000000000-00000     Document Type: Article

References (23)

1. Steinkamp G, Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 2002; 57 (7): 596-601 (Pubitemid 34761761)
2. Konstan MW, Butler SM, Wohl ME, et al. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003; 142 (6): 624-30 (Pubitemid 36737164)
3. Stallings VA, Stark LJ, Robinson KA, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008; 108 (5): 832-9 (Pubitemid 351602057)
4. Beker LT, Russek-Cohen E, Fink RJ. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc 2001; 101 (4): 438-42 (Pubitemid 33712127)
5. Sinaasappel M, Stern M, Littlewood J, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002; 1 (2): 51-75
6. Conway SP, Morton A, Wolfe S. Enteral tube feeding for cystic fibrosis. Cochrane Database Syst Rev 2008; (2): CD001198
7. Van Biervliet S, De Waele K, Van Winckel M, et al. Percutaneous endoscopic gastrostomy in cystic fibrosis: patient acceptance and effect of overnight tube feeding on nutritional status. Acta Gastroenterol Belg 2004; 67 (3): 241-4 (Pubitemid 39486927)
8. Williams SG, Ashworth F, McAlweenie A, et al. Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis. Gut 1999; 44 (1): 87-90 (Pubitemid 29143285)
9. Abbott Laboratories. CREON (pancrelipase) Delayed- Release Capsules prescribing information. Marietta (GA): Abbott Laboratories, August 2010 [online]. Available from URL: http://www.rxabbott.com/pdf/creon-PI.pdf [Accessed 2011 Apr 4]
10. Graff GR, Maguiness K, McNamara J, et al. Efficacy and tolerability of a new formulation of pancrelipase delayedrelease capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Clin Ther 2010; 32 (1): 89-103
11. Stern RC, Eisenberg JD,Wagener JS, et al. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Am J Gastroenterol 2000; 95 (8): 1932-8
12. Trapnell BC, Maguiness K, Graff GR, et al. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros 2009; 8 (6): 370-7
13. Whitcomb DC, Lehman GA, Vasileva G, et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial. Am J Gastroenterol 2010; 105: 2276-86
14. Safdi M, Bekal PK, Martin S, et al. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas 2006; 33 (2): 156-62 (Pubitemid 44174563)
15. Graff GR, McNamara J, Royall J, et al. Safety and tolerability of a new formulation of pancrelipase delayedrelease capsules (CREON-) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. Clin Drug Investig 2010; 30 (6): 351-64
16. Munck A, Duhamel JF, Lamireau T, et al. Pancreatic enzyme replacement therapy for young cystic fibrosis patients. J Cyst Fibros 2009; 8 (1): 14-8
17. Colombo C, Fredella C, Russo MC, et al. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study. Pancreas 2009; 38 (6): 693-9
18. Gubergrits N, Malecka-Panas E, Lehman GA, et al. A 6-month, open-label clinical trial of pancrelipase delayedrelease capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther 2011; 33 (10): 1152-61
19. United States Pharmacopeia. Pancrelipase delayed-release capsules monograph. The United States Pharmacopeia 33-National Formulary 28 (USP 33-NF 28). Rockville (MD): United States Pharmacopeia, 2009
20. European Directorate for the Quality of Medicines. 2.9.3 Dissolution test for solid dosage forms 6.6-5091. 6th ed (suppl. 6.7). European Pharmacopoeia; 2008
21. Smieja M. Procedure for administration of PANCRECARB (pancrelipase) MS-4 in applesauce through a MIC-KEY gastrostomy tube. Bethlehem (PA): Digestive Care, Inc. [online]. Available from URL: http://www.digestive care.com/pdf/Applesauce-Procedure.pdf [Accessed 2011 Apr 21]
22. Warren WS, Pallone M, McClure M. Evaluation of an enteric- coated buffered pancreatic enzyme product in cystic fibrosis patients with gastrostomy tube. Am J Gastroenterol 2009; 104: S60-81
23. Ferrie S, Graham C, Hoyle M. Pancreatic enzyme supplementation for patients receiving enteral feeds. Nutr Clin Pract. Epub 2011 Apr 20